slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 40,681-40,710
Pages 3,683
Rows per page 30
Component
40,681-40,710 of 110,471
19
The slide uses a two-column list structure to categorize innovations, followed by three SEM images as visual proof.Dragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations Beat · Business Model2 hits
06
The slide uses a yellow sidebar for branding and highlights two key product features with screenshots.eBay | Results Presentation Deck | 35 slides · eBay
Conference presentation Investor relations Beat · NeedLoop · Logic Chain2 hits
19
The chart visualizes the net debt position by subtracting debt from cash/investments.eBay | Results Presentation Deck | 35 slides · eBay
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain2 hits
14
The slide uses a comparison frame to contrast summer and winter peak demand profiles, highlighting the inadequacy of 4-hour storage for winter needs.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action2 hits
15
The slide uses a process flow for the utility side and a stakeholder/financing flow for the developer side.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action2 hits
06
Includes specific financial breakdown of deal value and R&D funding obligations.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution2 hits
07
The slide uses a side-by-side comparison structure to detail trial status and upcoming milestones for two distinct clinical programs.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution2 hits
36
The slide uses a timeline framework to map patent coverage and exclusivity periods across two main product categories.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 2 hits
14
Includes two waterfall plots comparing patient responses; source cited as Novartis materials.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needs2 hits
15
The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needsLoop · Cost Of Inaction2 hits
16
Uses a multiplicative framework (Active Buyers x Frequency x AOV) to explain GMS growth drivers.Etsy | Investor Presentation Deck | 26 slides · Etsy
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
18
Etsy | Investor Presentation Deck | 26 slidesEtsy | Investor Presentation Deck | 26 slides · Etsy
Pitch deck Investor relations Beat · Market Size2 hits
13
Slide 13 of a presentation deck.Etsy | Results Presentation Deck | 35 slides · Etsy
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet2 hits
02
Eutelsat | Investor Presentation Deck | 63 slidesEutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations 2 hits
05
Eutelsat | Investor Presentation Deck | 63 slidesEutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations 2 hits
08
Eutelsat | Investor Presentation Deck | 63 slidesEutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations 2 hits
34
Includes guidance horizon markers for FY23PF to FY25e.Eutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations 2 hits
31
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
33
Includes a biological pathway diagram and a honeycomb diagram for indications.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
41
The slide showcases a successful asset development case study involving AI-driven design.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
45
Uses MIDD (Model-informed drug development) as a core methodology.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
48
Includes a biological pathway diagram and supporting bullet points on therapeutic mechanism and safety profile.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
61
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
62
MIDD = Model-informed Drug DevelopmentExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
71
The slide demonstrates efficacy and synergy in vivo for a drug candidate ('565) in DLBCL models.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
73
The table uses a heatmap-style color coding (red/green) to indicate risk levels for UGT1A1 inhibition parameters.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
74
The slide uses a two-column layout to contrast PK data with Toxicology/Safety data.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
75
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
07
Uses MIDD (Model-informed drug development) as a strategic framework for clinical progression.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain2 hits
10
The slide uses a process flow to show the mechanism of action for a drug candidate.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · EvidenceLoop · Before After2 hits